In addition, residual confounding may exist in the use of self-reported height, weight and history of hypertension, and information on family history of type 2 diabetes and pharmacological therapy that may affect glucose and RBP4 levels was not collected. This evidence concerns the gene RBP4 and hypertensive disorder.